These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 30439342)

  • 1. Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages.
    Zimmerman MG; Quicke KM; O'Neal JT; Arora N; Machiah D; Priyamvada L; Kauffman RC; Register E; Adekunle O; Swieboda D; Johnson EL; Cordes S; Haddad L; Chakraborty R; Coyne CB; Wrammert J; Suthar MS
    Cell Host Microbe; 2018 Nov; 24(5):731-742.e6. PubMed ID: 30439342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy.
    Brown JA; Singh G; Acklin JA; Lee S; Duehr JE; Chokola AN; Frere JJ; Hoffman KW; Foster GA; Krysztof D; Cadagan R; Jacobs AR; Stramer SL; Krammer F; García-Sastre A; Lim JK
    Immunity; 2019 Mar; 50(3):751-762.e5. PubMed ID: 30737148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.
    Londono-Renteria B; Troupin A; Cardenas JC; Hall A; Perez OG; Cardenas L; Hartstone-Rose A; Halstead SB; Colpitts TM
    J Gen Virol; 2017 Jul; 98(7):1702-1712. PubMed ID: 28691657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika virus infection in human placental tissue explants is enhanced in the presence of dengue virus antibodies in-vitro.
    Hermanns K; Göhner C; Kopp A; Schmidt A; Merz WM; Markert UR; Junglen S; Drosten C
    Emerg Microbes Infect; 2018 Dec; 7(1):198. PubMed ID: 30504926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
    Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
    J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.
    Pantoja P; Pérez-Guzmán EX; Rodríguez IV; White LJ; González O; Serrano C; Giavedoni L; Hodara V; Cruz L; Arana T; Martínez MI; Hassert MA; Brien JD; Pinto AK; de Silva A; Sariol CA
    Nat Commun; 2017 Jun; 8():15674. PubMed ID: 28643775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis.
    Langerak T; Mumtaz N; Tolk VI; van Gorp ECM; Martina BE; Rockx B; Koopmans MPG
    PLoS Pathog; 2019 Apr; 15(4):e1007640. PubMed ID: 30998804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
    Dejnirattisai W; Supasa P; Wongwiwat W; Rouvinski A; Barba-Spaeth G; Duangchinda T; Sakuntabhai A; Cao-Lormeau VM; Malasit P; Rey FA; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2016 Sep; 17(9):1102-8. PubMed ID: 27339099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?
    Gunawardana SA; Shaw RH
    BMC Infect Dis; 2018 Dec; 18(1):641. PubMed ID: 30526531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Reactive Antibodies during Zika Virus Infection: Protection, Pathogenesis, and Placental Seeding.
    Zimmerman MG; Wrammert J; Suthar MS
    Cell Host Microbe; 2020 Jan; 27(1):14-24. PubMed ID: 31917957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
    Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
    PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses.
    Pérez-Guzmán EX; Pantoja P; Serrano-Collazo C; Hassert MA; Ortiz-Rosa A; Rodríguez IV; Giavedoni L; Hodara V; Parodi L; Cruz L; Arana T; White LJ; Martínez MI; Weiskopf D; Brien JD; de Silva A; Pinto AK; Sariol CA
    Nat Commun; 2019 Sep; 10(1):4316. PubMed ID: 31541110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.